CLASS II Drug recall · Reported 31 May 2023 · FDA Enforcement Report
oxyTOCIN added to 0.9% sodium chloride recalled
Central Admixture Pharmacy Services is recalling oxyTOCIN added to 0.9% sodium chloride per, distributed nationwide in the US. The recall was initiated on 28 Apr 2023 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0710-2023
- FDA event ID
- 92253
- Recalling firm
- Central Admixture Pharmacy Services, Allentown, PA
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 28 Apr 2023
- FDA classified
- 19 May 2023
- Reported
- 31 May 2023
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 28 Apr 2023 | Recall initiated by company | |
| 19 May 2023 | Classified by FDA | +21 days |
| 31 May 2023 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
oxyTOCIN 30 units added to 0.9% sodium chloride 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6044-1.
Where it was distributed
Nationwide in the USA.
Questions about this recall
Why was it recalled?
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Which lots are affected?
Lot # 37-883041, 37-883043, 37-883044, 37-883045, 37-883047, 37-883059, 37-883060, 37-883067, 37-883071, 37-883072, 37-883131, 37-883185, Exp 04/28/2023; 37-883492, 37-883499, 37-883501, 37-883503, 37-883514, 37-883525, 37-883526, 37-883539, 37-883540, 37-883548, 37-883549, 37-883550, 37-883551, Exp 05/01/2023; 37-884229, 37-884230, 37-884245, 37-884249, 37-884252, 37-884256, 37-884260, 37-884261, 37-884262, 37-884266, 37-884270, Exp 05/03/2023; 37-884452, 37-884453, 37-884457, 37-884461, 37-884464, 37-884466, 37-884468, 37-884470, 37-884472, 37-884473, Exp 05/04/2023; 37-884793, 37-884812, 37-884817, 37-884821, 37-884822, 37-884830, 37-884833, 37-884874, 37-884881, 37-884886, 37-884895, 37-884905, 37-884907, 37-884916, 37-884917, Exp 05/05/2023; 37-884807, 37-884941, 37-884942, 37-884943, 37-884944, 37-884945, 37-884946, 37-884954, 37-884955, 37-884956, Exp 05/07/2023; 37-885187, 37-885217, 37-885244, 37-885247, 37-885261, 37-885268, 37-885279, 37-885282, 37-885291, 37-885293, Exp 05/08/2023; 37-885584, 37-885598, 37-885608, Exp 05/09/2023; 37-886056, 37-886057, 37-886060, 37-886081, 37-886082, 37-886088, 37-886089, Exp 05/10/2023; 37-886251, 37-886256, 37-886257, 37-886259, 37-886263, 37-886264, Exp 05/11/2023; 37-886499, 37-886503, 37-886510, 37-886527, 37-886530, 37-886532, 37-886534, 37-886538, 37-886541, 37-886542, 37-886543, Exp 05/14/2023; 37-887304, 37-887306, 37-887307, 37-887308, 37-887309, 37-887310, 37-887311, 37-887312, Exp 05/16/2023; 37-887672, 37-887693, 37-887718, 37-887724, 37-887728, 37-887753, Exp 05/17/2023; 37-888081, 37-888082, 37-888084, 37-888086, Exp 05/18/2023; 37-888304, 37-888305, 37-888307, 37-888309, 37-888312, 37-888313, 37-888315, 37-888316, Exp 05/21/2023; 37-888695, 37-888705, 37-888722, 37-888742, 37-888764, Exp 05/22/2023; 37-889048, 37-889049, 37-889061, 37-889065, 37-889118, 37-889133, 37-889139, Exp 05/23/2023; 37-889530, 37-889534, 37-889541, 37-889561, 37-889562, 37-889563, 37-889571, 37-889573, 37-889703, Exp 05/24/2023; 37-889733, 37-889747, 37-889793, 37-889803, 37-889828, 37-889829, 37-889839, 37-889841, 37-889847, 37-889851, Exp 05/25/2023; 37-890413, 37-890419, 37-890427, 37-890430, 37-890435, 37-890443, 37-890444, 37-890473, Exp 05/29/2023; 37-890958, Exp 05/30/2023; 37-891217, 37-891221, 37-891224, 37-891229, 37-891231, 37-891233, 37-891248, Exp 05/31/2023; 37-891475, 37-891479, 37-891481, 37-891484, 37-891486, 37-891488, 37-891531, 37-891549, 37-891550, 37-891562, Exp 06/01/2023; 37-892164, 37-892183, 37-892195, Exp 06/05/2023; 37-892878, 37-892883, 37-892885, 37-892891, 37-892892, 37-892895, 37-892896, Exp 06/07/2023; 37-893167, 37-893168, 37-893200, 37-893203, 37-893205, 37-893206, 37-893219, Exp 06/08/2023; 37-893457, 37-893462, 37-893468, Exp 06/11/2023; 37-893798, 37-893799, 37-893808, 37-893809, 37-893814, 37-893844, Exp 06/12/2023; 37-894655, 37-894661, 37-894664, 37-894666, 37-894686, 37-894703, Exp 06/14/2023; 37-895029, 37-895030, 37-895036, 37-895037, 37-895038, 37-895048, 37-895056, 37-895063, 37-895068, 37-895072, 37-895073, 37-895074, 37-895075, Exp 06/15/2023; 37-895260, 37-895271, 37-895273, 37-895274, Exp 06/18/2023; 37-895623, 37-895624, 37-895644, 37-895653, 37-895661, 37-895676, 37-895677, 37-895678, 37-895679, 37-895774, 37-895776, Exp 06/19/2023; 37-896536, 37-896540, 37-896541, 37-896542, 37-896543, 37-896547, 37-896566, 37-896585, 37-896587, 37-896596, 37-896597, 37-896598, 37-896599, 37-896615, Exp 06/21/2023; 37-896864, 37-896868, 37-896870, 37-896877, 37-896879, 37-896882, 37-896882, 37-896885, 37-896899, 37-896901, 37-896903, 37-896914, 37-896915, 37-896916, Exp 06/22/2023; 37-897454, 37-897500, Exp 06/26/2023; 37-898273, Exp 06/28/2023; 37-898517, Exp 06/29/2023
Where was it sold?
Nationwide in the USA.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
100 other products · FDA event 92253This product is part of a recall event; the main page for the event is vasopressin added to 0.9% sodium chloride*/mL* recalled.